The neurocircuitry of addiction: Implications for treatment

Clinical Neuroscience Research

Volumn 5, Issue 2-4, 2005, Pages 89-101

  Koob, George F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Allostasis; Brain stress systems; Drug addiction; Extended amygdala; Neurochemical mechanisms; Neurocircuitry

Indexed keywords

4 AMINOBUTYRIC ACID; ALCOHOL; AMPHETAMINE DERIVATIVE; COCAINE; CORTICOTROPIN RELEASING FACTOR; DOPAMINE; DRONABINOL; GLUTAMIC ACID; NEUROPEPTIDE Y; NICOTINE; NORADRENALIN; OPIATE; OPIATE PEPTIDE; PSYCHOSTIMULANT AGENT;

ADAPTATION; AMYGDALOID NUCLEUS; ARTICLE; BEHAVIOR THERAPY; CHRONIC DISEASE; COMPULSION; DRUG ABUSE; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG TARGETING; DRUG WITHDRAWAL; FOREBRAIN; HOMEOSTASIS; HUMAN; MOTIVATION; NERVE CELL NETWORK; NEUROCHEMISTRY; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REINFORCEMENT; RELAPSE; REWARD; STRESS; WITHDRAWAL SYNDROME;

EID: 27944465654     PISSN: 15662772     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cnr.2005.08.005     Document Type: Article

References (91)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 4th ed. 1994 American Psychiatric Press Washington, DC
2. G.F. Koob M. Le Moal Drug abuse: Hedonic homeostatic dysregulation Science 278 1997 52-58
3. Allostatic view of motivation: Implications for psychopathology In: R.A. Bevins M.T. Bardo editors. Motivational factors in the etiology of drug abuse Nebraska symposium on motivation vol. 50 2004 University of Nebraska Press Lincoln, NE 1-18
4. G.F. Koob M. Le Moal Drug addiction, dysregulation of reward, and allostasis Neuropsychopharmacology 24 2001 97-129
5. G.F. Koob M.R.A. Carrera L.H. Gold et al. Substance dependence as a compulsive behavior J Psychopharmacol 12 1998 39-48
6. M. Le Moal H. Simon Mesocorticolimbic dopaminergic network: Functional and regulatory roles Physiol Rev 71 1991 155-234
7. H.O. Pettit A. Ettenberg F.E. Bloom G.F. Koob Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats Psychopharmacology 84 1984 167-173
8. S. Rassnick L. Stinus G.F. Koob The effects of 6-hydroxydopamine lesions of the nucleus accumbens and the mesolimbic dopamine system on oral self-administration of ethanol in the rat Brain Res 623 1993 16-24
9. G.F. Alheid J.S. De Olmos C.A. Beltramino Amygdala and extended amygdala In: G. Paxinos editor. The rat nervous system 1995 Academic Press San Diego 495-578
10. L. Heimer G. Alheid Piecing together the puzzle of basal forebrain anatomy In: T.C. Napier P.W. Kalivas I. Hanin editors. The basal forebrain: Anatomy to function Advances in experimental medicine and biology vol. 295 1991 Plenum Press New York 1-42
11. G.F. Koob Drugs of abuse: Anatomy, pharmacology, and function of reward pathways Trends Pharmacol Sci 13 1992 177-184
12. G.F. Koob Hedonic valence, dopamine, and motivation Mol Psychiatry 1 1996 186-189
13. G.F. Koob P.P. Sanna F.E. Bloom Neuroscience of addiction Neuron 21 1998 467-476
14. F.E. Pontieri G. Tanda G. Di Chiara Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the 'shell' as compared with the 'core' of the rat nucleus accumbens Proc Natl Acad Sci USA 92 1995 12304-12308
15. J. Diaz D. Lévesque C.H. Lammers et al. Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain Neuroscience 65 1995 731-745
16. S.B. Caine S.C. Heinrichs V.L. Coffin G.F. Koob Effects of the dopamine D1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat Brain Res 692 1995 47-56
17. M.P. Epping-Jordan A. Markou G.F. Koob The dopamine D-1 receptor antagonist SCH 23390 injected into the dorsolateral bed nucleus of the stria terminalis decreased cocaine reinforcement in the rat Brain Res 784 1998 105-115
18. P. Hyytia G.F. Koob GABA-A receptor antagonism in the extended amygdala decreases ethanol self-administration in rats Eur J Pharmacol 283 1995 151-159
19. C.J. Heyser A.J. Roberts G. Schulteis G.F. Koob Central administration of an opiate antagonist decreases oral ethanol self-administration in rats Alcohol Clin Exp Res 23 1999 1468-1476
20. E.J. Khantzian The self-medication hypothesis of substance use disorders: A reconsideration and recent applications Harvard Rev Psychiatry 4 1997 231-244
21. E.J. Khantzian A. Wilson Substance abuse, repetition, and the nature of addictive suffering In: A. Wilson J.E. Gedo editors. Hierarchical concepts in psychoanalysis: Theory, research, and clinical practice 1993 Guilford Press New York 263-283
22. G.F. Koob The neurobiology of self-regulation failure in addiction: An allostatic view [commentary on Khantzian, 'Understanding addictive vulnerability: An evolving psychodynamic perspective'] Neuro-Psychoanalysis 5 2003 35-39
23. N.E. Paterson C. Myers A. Markou Effects of repeated withdrawal from continuous amphetamine administration on brain reward function in rats Psychopharmacology 152 2000 440-446
24. G. Schulteis A. Markou M. Cole G. Koob Decreased brain reward produced by ethanol withdrawal Proc Natl Acad Sci USA 92 1995 5880-5884
25. A. Markou G.F. Koob Post-cocaine anhedonia: An animal model of cocaine withdrawal Neuropsychopharmacology 4 1991 17-26
26. G. Schulteis A. Markou L.H. Gold L. Stinus G.F. Koob Relative sensitivity to naloxone of multiple indices of opiate withdrawal: A quantitative dose-response analysis J Pharmacol Exp Ther 271 1994 1391-1398
27. M.P. Epping-Jordan S.S. Watkins G.F. Koob A. Markou Dramatic decreases in brain reward function during nicotine withdrawal Nature 393 1998 76-79
28. E.L. Gardner S.R. Vorel Cannabinoid transmission and reward-related events Neurobiol Dis 5 1998 502-533
29. C. Van Dyke R. Byck Cocaine Sci Am 246 1982 128-141
30. P.J. Kenny I. Polis G.F. Koob A. Markou Low dose cocaine self-administration transiently increases but high dose cocaine persistently decreases brain reward function in rats Eur J Neurosci 17 2003 191-195
31. S.H. Ahmed P.J. Kenny G.F. Koob A. Markou Neurobiological evidence for hedonic allostasis associated with escalating cocaine use Nat Neurosci 5 2002 625-626
32. Ahmed SH, Koob GF. The transition to drug addiction: A reward allostasis model explains escalated drug intake. Psychopharmacology, [in press].
33. S.H. Ahmed G.F. Koob Transition from moderate to excessive drug intake: change in hedonic set point Science 282 1998 298-300
34. S.H. Ahmed G.F. Koob Long-lasting increase in the set point for cocaine self-administration after escalation in rats Psychopharmacology 146 1999 303-312
35. S.H. Ahmed G.F. Koob Changes in response to a dopamine antagonist in rats with escalating cocaine intake Psychopharmacology 172 2004 450-454
36. S.H. Ahmed D. Lin G.F. Koob L.H. Parsons Escalation of cocaine self-administration does not depend on altered cocaine-induced nucleus accumbens dopamine levels J Neurochem 86 2003 102-113
37. O. Ben-Shahar S.H. Ahmed G.F. Koob A. Ettenberg The transition from controlled to compulsive drug use is associated with a loss of sensitization Brain Res 995 2004 46-54
38. Kitamura O, Koob GF, Pulvirenti L. Effects of the dopamine partial agonist terguride on methamphetamine self-administration in an escalation model. 2005. Submitted for publication.
39. S.H. Ahmed J.R. Walker G.F. Koob Persistent increase in the motivation to take heroin in rats with a history of drug escalation Neuropsychopharmacology 22 2000 413-421
40. J.R. Walker S.A. Chen H. Moffitt C.E. Inturrisi G.F. Koob Chronic opioid exposure produces increased heroin self-administration in rats Pharmacol Biochem Behav 75 2003 349-354
41. R. Spanagel F. Weiss The dopamine hypothesis of reward: Past and current status Trends Neurosci 22 1999 521-527
42. N.D. Volkow J.S. Fowler G.J. Wang The addicted human brain: Insights from imaging studies J Clin Invest 111 2003 1444-1451
43. E.J. Nestler Historical review: Molecular and cellular mechanisms of opiate and cocaine addiction Trends Pharmacol Sci 25 2004 210-218
44. L.W. Swanson P.E. Sawchenko J. Rivier W. Vale The organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: An immunohistochemical study Neuroendocrinology 36 1983 165-186
45. A.J. Dunn C.W. Berridge Physiological and behavioral responses to corticotropin-releasing factor administration: Is CRF a mediator of anxiety or stress responses? Brain Res Rev 15 1990 71-100
46. G.F. Koob S.C. Heinrichs F. Menzaghi E.M. Pich K.T. Britton Corticotropin releasing factor, stress and behavior Seminars Neurosci 6 1994 221-229
47. G.F. Koob T. Bartfai A.J. Roberts The use of molecular genetic approaches in the neuropharmacology of corticotropin-releasing factor Int J Comp Psychol 14 2001 90-110
48. Z. Sarnyai Y. Shaham S.C. Heinrichs The role of corticotropin-releasing factor in drug addiction Pharmacol Rev 53 2001 209-243
49. G.F. Koob S.C. Heinrichs A role for corticotropin-releasing factor and urocortin in behavioral responses to stressors Brain Res 848 1999 141-152
50. M. Spina E. Merlo-Pich R.K.W. Chan et al. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide Science 273 1996 1561-1564
51. M.A. Pelleymounter M. Joppa M. Carmouche et al. Role of corticotropin-releasing factor (CRF) receptors in the anorexic syndrome induced by CRF J Pharmacol Exp Ther 293 2000 799-806
52. C. Rivier T. Bruhn W. Vale Effect of ethanol on the hypothalamic-pituitary-adrenal axis in the rat: Role of corticotropin-releasing factor (CRF) J Pharmacol Exp Ther 229 1984 127-131
53. D.D. Rasmussen B.M. Boldt C.A. Bryant D.R. Mitton S.A. Larsen C.W. Wilkinson Chronic daily ethanol and withdrawal: 1. Long-term changes in the hypothalamo-pituitary-adrenal axis Alcohol Clin Exp Res 24 2000 1836-1849
54. S. Rassnick S.C. Heinrichs K.T. Britton G.F. Koob Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal Brain Res 605 1993 25-32
55. S.C. Heinrichs F. Menzaghi G. Schulteis G.F. Koob L. Stinus Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal Behav Pharmacol 6 1995 74-80
56. J.M. Delfs Y. Zhu J.P. Druhan G. Aston-Jones Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion Nature 403 2000 430-434
57. K.N. Gracy L.A. Dankiewicz G.F. Koob Opiate withdrawal-induced Fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion Neuropsychopharmacology 24 2001 152-160
58. E. Merlo-Pich M. Lorang M. Yeganeh et al. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis J Neurosci 15 1995 5439-5447
59. M.F. Olive H.N. Koenig M.A. Nannini C.W. Hodge Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake Pharmacol Biochem Behav 72 2002 213-220
60. E.P. Zorrilla G.R. Valdez F. Weiss Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats Psychopharmacology 158 2001 374-381
61. F. Weiss R. Ciccocioppo L.H. Parsons et al. Compulsive drug-seeking behavior and relapse: Neuroadaptation, stress, and conditioning factors In: V. Quinones-Jenab editor. The biological basis of cocaine addiction Annals of the New York Academy of Sciences vol. 937 2001 New York Academy of Sciences New York 1-26
62. R.M. Richter F. Weiss In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats Synapse 32 1999 254-261
63. F. Rodriguez de Fonseca M.R.A. Carrera M. Navarro G.F. Koob F. Weiss Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal Science 276 1997 2050-2054
64. S. Ghozland E. Zorrilla L.H. Parsons G.F. Koob Mecamylamine increases extracellular CRF levels in the central nucleus of the amygdala or nicotine-dependent rats Society Neurosci Abstr 30 2004 7088
65. G.R. Valdez A.J. Roberts K. Chan et al. Increased ethanol self-administration and anxiety-like behavior during acute withdrawal and protracted abstinence: Regulation by corticotropin-releasing factor Alcohol Clin Exp Res 26 2002 1494-1501
66. S.E. Specio E.P. Zorrilla L.E. O'Dell et al. Systemic administration of CRF1 receptor antagonists decrease cocaine self-administration in escalated and non-escalated rats Society Neurosci Abstr 30 2004 77711
67. A. Roy S.C. Pandey The decreased cellular expression of neuropeptide Y protein in rat brain structures during ethanol withdrawal after chronic ethanol exposure Alcohol Clin Exp Res 26 2002 796-803
68. C.J. Slawecki C. Somes C.L. Ehlers Effects of chronic ethanol exposure on neurophysiological responses to corticotropin-releasing factor and neuropeptide Y Alcohol Alcohol 34 1999 289-299
69. N.E. Badia-Elder R.B. Stewart T.A. Powrozek K.F. Roy J.M. Murphy T.K. Li Effect of neuropeptide Y (NPY) on oral ethanol intake in Wistar, alcohol-preferring (P), and -nonpreferring (NP) rats Alcohol Clin Exp Res 25 2001 386-390
70. P.W. Kalivas K. McFarland Brain circuitry and the reinstatement of cocaine-seeking behavior Psychopharmacology 168 2003 44-56
71. R. Ito T.W. Robbins B.J. Everitt Differential control over cocaine-seeking behavior by nucleus accumbens core and shell Nat Neurosci 7 2004 389-397
72. R.E. See R.A. Fuchs C.C. Ledford J. McLaughlin Drug addiction, relapse, and the amygdala In: P. Shinnick-Gallagher A. Pitkanen A. Shekhar L. Cahill editors. The amygdala in brain function: Basic and clinical approaches Annals of the New York Academy of Sciences vol. 985 2003 New York Academy of Sciences New York 294-307
73. Y. Shaham S. Erb J. Stewart Stress-induced relapse to heroin and cocaine seeking in rats: A review Brain Res Rev 33 2000 13-33
74. R.M. Salimov N.B. Salimova The alcohol-deprivation effect in hybrid mice Drug Alcohol Depend 32 1993 187-191
75. J. Le Magnen Etude de quelques facteurs associe a des modification de la consommation spontanee d'alcool ethylique par le rat [Study of some factors associated with modifications of spontaneous ingestion of ethyl alcohol by the rat] J Physiol (Paris) 52 1960 873-884
76. J.D. Sinclair R.J. Senter Increased preference for ethanol in rats following alcohol deprivation Psychonom Sci 8 1967 11-12
77. J.D. Sinclair R.J. Senter Development of an alcohol-deprivation effect in rats Q J Stud Alcohol 29 1968 863-867
78. R. Spanagel S.M. Hölter K. Allingham R. Landgraf W. Zieglgänsberger Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat Eur J Pharmacol 305 1996 39-44
79. M. Kornet C. Goosen J.M. Van Ree The effect of interrupted alcohol supply on spontaneous alcohol consumption by rhesus monkeys Alcohol Alcohol 25 1990 407-412
80. M. Kornet C. Goosen J.M. Van Ree Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys Psychopharmacology 104 1991 367-376
81. T.G. Burish S.A. Maisto A.M. Cooper M.B. Sobell Effects of voluntary short-term abstinence from alcohol on subsequent drinking patterns of college students J Stud Alcohol 42 1981 1013-1020
82. A.J. Roberts C.J. Heyser M. Cole P. Griffin G.F. Koob Excessive ethanol drinking following a history of dependence: Animal model of allostasis Neuropsychopharmacology 22 2000 581-594
83. C.J. Heyser G. Schulteis G.F. Koob Increased ethanol self-administration after a period of imposed ethanol deprivation in rats trained in a limited access paradigm Alcohol Clin Exp Res 21 1997 784-791
84. R. Spanagel S.M. Holter Long-term alcohol self-administration with repeated alcohol deprivation phases: An animal model of alcoholism? Alcohol Alcohol 34 1999 231-243
85. B.S. McEwen Protective and damaging effects of stress mediators New England J Med 338 1998 171-179
86. P. Sterling J. Eyer Allostasis: A new paradigm to explain arousal pathology In: S. Fisher J. Reason editors. Handbook of life stress, cognition and health 1988 Chichester John Wiley 629-649
87. G.F. Koob Corticotropin-releasing factor, norepinephrine and stress Biol Psychiatry 46 1999 1167-1180
88. G.F. Koob G.F. Koob M. Le Moal Drug addiction and allostasis In: J. Schulkin editor. Allostasis, homeostasis, and the costs of physiological adaptation 2004 Cambridge University Press New York 150-163
89. J.D. Jentsch J.R. Taylor Impulsivity resulting from frontostriatal dysfunction in drug abuse: Implications for the control of behavior by reward-related stimuli Psychopharmacology 146 1999 373-390
90. R.Z. Goldstein N.D. Volkow Drug addiction and its underlying neurobiological basis: Neuroimaging evidence for the involvement of the frontal cortex Am J Psychiatry 159 2002 1642-1652
91. R. Ito T.W. Robbins B.J. Everitt Differential control over cocaine-seeking behavior by nucleus accumbens core and shell Nat Neurosci 7 2004 389-397